Visceral Adiposity, Not Abdominal Subcutaneous Fat Area, Is Associated With an Increase in Future Insulin Resistance in Japanese Americans
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—Visceral adiposity is generally considered to play a key role in the metabolic syndrome. We sought to determine whether greater visceral adiposity directly measured by computed tomography (CT) is associated with increased future insulin resistance independent of other adipose depots. RESEARCH DESIGN AND METHODS— We followed 306 nondiabetic Japanese Americans over 10–11 years. Baseline variables included BMI; waist circumference; and abdominal, thoracic, and thigh fat areas measured by CT. Total fat area was estimated by the sum of all of these fat areas. Visceral adiposity was measured as intra-abdominal fat area at the umbilicus level. Total subcutaneous fat area was defined as total fat area minus intra-abdominal fat area. Insulin resistance was evaluated by homeostasis model assessment for insulin resistance (HOMA-IR), fasting plasma insulin level, Matsuda index, and area under the oral glucose tolerance test curve (AUC) of insulin. RESULTS— Both baseline intra-abdominal fat area (P = 0.002) and HOMA-IR (P < 0.001) were independently associated with increased HOMA-IR at 10–11 years in a multiple linear regression model after adjustment for abdominal subcutaneous fat area, age, sex, 2-h plasma glucose level, and incremental insulin response. Intra-abdominal fat area remained a significant predictor of increased HOMA-IR at 10–11 years even after adjustment for total subcutaneous fat area, total fat area, BMI, or waist circumference, but no other measure of CT-measured regional or total adiposity was significantly related with HOMA-IR at 10–11 years in models that contained intra-abdominal fat area. Similar results were obtained for predicting future fasting plasma insulin level, Matsuda index, and AUC of insulin. CONCLUSIONS— Greater visceral adiposity is associated with an increase in future insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These changes are associated with insulin resistance, as opposed to insulin-sensitive obesity, which is associated with proportionally more healthy subcutaneous fat cells and less visceral fat (8,13,14).”
From Metformin in Gestational Diabetes: The Offspring Follow-Up (MiG TOFU) (2011) · cites this paper as [14]
Experimental — accuracy not yet measuredIn the citing paper
“The association between obesity and metabolic dysfunctions is predominantly dictated by fat distribution with increased visceral or intra-abdominal fat being more detrimental to metabolic health compared to peripheral adiposity depots, which appear to confer a better metabolic profile (Vazquez et al., 2007; Hayashi et al., 2008; Castro et al., 2014).”
From Mitochondrial (Dys)function and Insulin Resistance: From Pathophysiological Molecular Mechanisms to the Impact of Diet (2019) · cites this paper as Hayashi et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · cited 2×
“The homeostasis model assessment for insulin resistance (HOMA-IR) was developed to serve as a surrogate measure of insulin resistance that only requires assessment of basal glucose and insulin concentrations (8), and it, along with fasting plasma insulin, has frequently been used in epidemiological studies to assess i…”
BackgroundMethodReport of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 3×
“The purpose of this study was to determine whether greater visceral adiposity directly measured by computed tomography (CT) was associated independent of other adipose depots, with a future increase in insulin resistance as assessed by multiple measures, including HOMA-IR, fasting plasma insulin, the Matsuda index, an…”
BackgroundUse and Abuse of HOMA Modeling
Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1487 · Cited by 5,114 · cited 2×
“The homeostasis model assessment for insulin resistance (HOMA-IR) was developed to serve as a surrogate measure of insulin resistance that only requires assessment of basal glucose and insulin concentrations (8), and it, along with fasting plasma insulin, has frequently been used in epidemiological studies to assess i…”
MethodSubcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961 · cited 1×
“Adipocytederived proteins may also play a key role in the pathogenesis of peripheral insulin resistance (28).”
BackgroundRothman, K. J., Greenland, S., & Lash, T. L. (1998) · Cited by 2,096
New Criteria for `Obesity Disease' in Japan
The Examination Committee of Criter (2002) · Circulation Journal · doi:10.1253/circj.66.987 · Cited by 1,650
Cnop, M., Havel, P. J., Utzschneider, K. M., Carr, D. B., Sinha, M. K., Boyko, E. J., Retzlaff, B. M., Knopp, R. H., Brunzell, J. D., & Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-003-1074-z · Cited by 1,483 · cited 1×
“For instance, levels of the insulin-sensitizing adipocyte-derived protein adiponectin are reported to be positively related with insulin sensitivity (29).”
BackgroundSelf-citationPrimer of Applied Regression & Analysis of Variance
Glantz, S. A., & Slinker, B. K. (1990) · UCLA - Biblioteca de Ciencias y Tecnologia Felix Morales Bueno · Cited by 1,189
Cited by
Insulin resistance and hyperglycaemia in cardiovascular disease development
Laakso, M., & Kuusisto, J. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.29 · Cited by 858
Ma, R. C. W., & Chan, J. C. N. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12098 · Cited by 827
Gluteofemoral body fat as a determinant of metabolic health
Manolopoulos, K. N., Karpe, F., & Frayn, K. N. (2010) · International Journal of Obesity · doi:10.1038/ijo.2009.286 · Cited by 811
BMI Cut Points to Identify At-Risk Asian Americans for Type 2 Diabetes Screening
Hsu, W. C., Araneta, M. R. G., Kanaya, A. M., Chiang, J. L., & Fujimoto, W. (2015) · Diabetes Care · doi:10.2337/dc14-2391 · Cited by 500
Self-citationPreis, S. R., Massaro, J. M., Robins, S. J., Hoffmann, U., Vasan, R. S., Irlbeck, T., Meigs, J. B., Sutherland, P., D'Agostino Sr, R. B., O'Donnell, C. J., et al. (2010) · Obesity · doi:10.1038/oby.2010.59 · Cited by 412
Metadata
- Authors
- Hayashi, T., Boyko, E. J., McNeely, M. J., Leonetti, D. L., Kahn, S. E., & Fujimoto, W. Y.
- Affiliations
- Osaka City University (JP)
- University of Washington (US)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2008-05-01
- Volume
- 57
- Issue
- 5
- Pages
- 1269-1275
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2103410011
- Semantic Scholar
- 22bd8941bcf724a743d4b0c8c19f3b0046c5b082
- Cited by
- 207
- References
- 40
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 8 · 2023: 4 · 2022: 7 · 2021: 13 · 2020: 8 · 2019: 11 · 2018: 8 · 2017: 18 · 2016: 13 · 2015: 13 · 2014: 16 · 2013: 12 · 2012: 18
- FWCI
- 12.31
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- U.S. Department of Veterans Affairs
- University of Washington (DK17047, DK-35816, RR-00037)
- National Institutes of Health (DK-31170)
- National Heart, Lung, and Blood Institute (HL 49293, R01HL049293)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-35816, DK 31170, K24DK002654, DK 02654, DK-17047, P30DK035816, P30DK017047)
- National Center for Research Resources (RR00037)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R24HD042828)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- visceral fat, insulin resistance, intra-abdominal fat, subcutaneous abdominal fat, regional adiposity, metabolic syndrome, Japanese Americans, HOMA-IR, fasting insulin, Matsuda index, insulin sensitivity
- MeSH terms
- Abdomen, Adipose Tissue, Adult, Blood Glucose, Female, Follow-Up Studies, Humans, Insulin, Insulin Resistance, Inulin, Japan, Male, Middle Aged, United States, Viscera, Area Under Curve, Asian People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.